Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glulisine Injection Timing in Type 2 Diabetes
NCT00272012Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2004
- Primary completion
- Sep 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jul 2004; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00272012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00272012.